List of Figures
Figure 1: Colorectal Cancer Therapeutics, Global, European Society for Medical Oncology Treatment Guidelines (Colorectal Cancer at Stage I to III)
Figure 2: Colorectal Cancer Therapeutics, Global, European Society for Medical Oncology Treatment Guidelines (Colorectal Cancer at Stage IV)
Figure 3: Colorectal Cancer Therapeutics, Global, Heat Map (Marketed Products)
Figure 4: Colorectal Cancer Therapeutics, Global, Pipeline by Stage of Development and Program Type, 2014
Figure 5: Colorectal Cancer Therapeutics, Global, Pipeline by Molecule Type and Stage of Development, 2014
Figure 6: Colorectal Cancer Therapeutics, Global, Pipeline by Mechanism of Action and Stage of Development, 2014
Figure 7: Colorectal Cancer Therapeutics, Global, Clinical Trial Failure Rate (%), 2014
Figure 8: Colorectal Cancer Therapeutics, Global, Clinical Trial Size, 2014
Figure 9: Colorectal Cancer Therapeutics, Global, Clinical Trial Duration (months), 2014
Figure 10: Colorectal Cancer Therapeutics, Global, Treatment Use Patterns (‘000) and Market Size ($bn), 2013–2020
Figure 11: Colorectal Cancer Therapeutics, US and Canada, Treatment Use Patterns (‘000), 2013–2020
Figure 12: Colorectal Cancer Therapeutics, US and Canada, Annual Cost of Therapy ($), 2013–2020
Figure 13: Colorectal Cancer Therapeutics, US and Canada, Market Size ($m), 2013–2020
Figure 14: Colorectal Cancer Therapeutics, Top Five European Markets, Treatment Use Patterns (‘000), 2013–2020
Figure 15: Colorectal Cancer Therapeutics, Top Five European Markets, Annual Cost of Therapy ($), 2013–2020
Figure 16: Colorectal Cancer Therapeutics, Top Five European Markets, Market Size ($m), 2013–2020
Figure 17: Colorectal Cancer Therapeutics, Japan, Treatment Use Pattern, 2013–2020
Figure 18: Colorectal Cancer Therapeutics, Japan, Annual Cost of Therapy, 2013–2020
Figure 19: Colorectal Cancer Therapeutics, Japan, Market Size ($m), 2013–2020
Figure 20: Colorectal Cancer Therapeutics, Global, Licensing Deals by Geography, 2006–2014
Figure 21: Colorectal Cancer Therapeutics, Global, Licensing Deals by Phase, Value, Mechanism of Action, 2006–2014
Figure 22: Colorectal Cancer Market, Global, Co-development Deals by Geography and by Value, 2006–2014
Figure 23: GBI Research Market Forecasting Model